pioglitazone

Generic: pioglitazone

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pioglitazone
Generic Name pioglitazone
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

pioglitazone hydrochloride 45 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-6412
Product ID 50090-6412_f4fbafda-1f75-45ab-90cc-2ab67a9ae973
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA202467
Listing Expiration 2026-12-31
Marketing Start 2022-08-18

Pharmacologic Class

Classes
ppar alpha [cs] ppar gamma [cs] peroxisome proliferator receptor alpha agonist [epc] peroxisome proliferator receptor gamma agonist [epc] peroxisome proliferator-activated receptor activity [moa] thiazolidinedione [epc] thiazolidinediones [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500906412
Hyphenated Format 50090-6412

Supplemental Identifiers

RxCUI
312441
UNII
JQT35NPK6C

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pioglitazone (source: ndc)
Generic Name pioglitazone (source: ndc)
Application Number ANDA202467 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 45 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (50090-6412-0)
  • 90 TABLET in 1 BOTTLE (50090-6412-1)
source: ndc

Packages (2)

50090-6412-0 30 TABLET in 1 BOTTLE (50090-6412-0) 50090-6412-1 90 TABLET in 1 BOTTLE (50090-6412-1)

Ingredients (1)

pioglitazone hydrochloride (45 mg/1)

Linked Drug Pages (1)

Pioglitazone ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f4fbafda-1f75-45ab-90cc-2ab67a9ae973", "openfda": {"unii": ["JQT35NPK6C"], "rxcui": ["312441"], "spl_set_id": ["475c4f39-dd2a-48f9-a07c-9344bbda58a9"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-6412-0)", "package_ndc": "50090-6412-0", "marketing_start_date": "20230328"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-6412-1)", "package_ndc": "50090-6412-1", "marketing_start_date": "20230328"}], "brand_name": "Pioglitazone", "product_id": "50090-6412_f4fbafda-1f75-45ab-90cc-2ab67a9ae973", "dosage_form": "TABLET", "pharm_class": ["PPAR alpha [CS]", "PPAR gamma [CS]", "Peroxisome Proliferator Receptor alpha Agonist [EPC]", "Peroxisome Proliferator Receptor gamma Agonist [EPC]", "Peroxisome Proliferator-activated Receptor Activity [MoA]", "Thiazolidinedione [EPC]", "Thiazolidinediones [CS]"], "product_ndc": "50090-6412", "generic_name": "Pioglitazone", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pioglitazone", "active_ingredients": [{"name": "PIOGLITAZONE HYDROCHLORIDE", "strength": "45 mg/1"}], "application_number": "ANDA202467", "marketing_category": "ANDA", "marketing_start_date": "20220818", "listing_expiration_date": "20261231"}